A yeast-based reverse genetics system to generate HCoV-OC43 reporter viruses encoding an eighth sgRNA
preprint
OA: closed
Abstract
ABSTRACT Coronaviruses have large, positive-sense single-stranded RNA genomes that challenge conventional strategies for mutagenesis. Here, we report the development of a new reverse genetics system for the endemic human coronavirus (HCoV) OC43 that utilizes transformation-associated recombination (TAR) to assemble complete viral genomes from dsDNA genome fragments via homologous recombination in Saccharomyces cerevisiae . Following cDNA synthesis from HCoV-OC43 viral RNA, we used TAR to capture fragments of the HCoV-OC43 genome to store as sequence-validated dsDNA parts. We performed combinatorial assembly in yeast to obtain an intact dsDNA copy of the HCoV-OC43 genome sufficient to launch viral replication upon introduction into human cells, yielding the yeast assembled OC43 YA virus. We also expanded the OC43 YA genome by inserting an eighth body transcription regulatory sequence (B-TRS) and an mClover3-H2B reporter gene between the M and N genes, designed to allow the reporter protein to be translated from its own subgenomic mRNA. We thoroughly evaluated OC43 YA and the OC43-mClo YA reporter virus, and demonstrated comparable viral gene expression, fitness in cell culture, and susceptibility to antivirals, compared to their natural progenitor. In summary, this new HCoV-OC43 reverse genetics system provides a modular platform for mutagenesis and combinatorial assembly of HCoV-OC43 genomes, and demonstrates the feasibility of expanding the genome while avoiding disruption of native coding sequences. IMPORTANCE Human coronavirus OC43 (HCoV-OC43) is an endemic human coronavirus that typically causes relatively mild respiratory illnesses and displays seasonal patterns of infection. We developed a new system to assemble DNA copies of HCoV-OC43 genomes and generate recombinant viruses for research purposes. This system uses yeast, first to capture segments of DNA encompassing the entire RNA-based viral genome, and then to stitch them together into complete DNA genome copies that can be amplified in bacteria and introduced into human cells to initiate an infectious cycle, ultimately yielding recombinant viruses with comparable properties to their natural progenitors. We also devised a strategy to expand the viral genome, adding a gene for a reporter protein encoded by an additional eighth subgenomic mRNA. This yeast-based genome assembly system provides a modular platform for rapid mutagenesis and combinatorial assembly of HCoV-OC43 genomes and demonstrates the feasibility of expanding the genome.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (81)
- doi:10.1371/journal.ppat.1007314 via crossref
- doi:10.1016/j.tibs.2021.05.006 via crossref
- doi:10.1038/s41580-021-00432-z via crossref
- doi:10.1073/pnas.2221324120 via crossref
- doi:10.1016/j.imbio.2022.152302 via crossref
- doi:10.1073/pnas.86.14.5626 via crossref
- doi:10.1128/jvi.64.3.1050-1056.1990 via crossref
- doi:10.1128/jvi.65.1.320-325.1991 via crossref
- doi:10.1128/jvi.66.4.1841-1848.1992 via crossref
- doi:10.1128/jvi.77.21.11312-11323.2003 via crossref
- doi:10.1186/s12985-017-0775-8 via crossref
- doi:10.1073/pnas.97.10.5516 via crossref
- doi:10.1128/jvi.74.22.10600-10611.2000 via crossref
- doi:10.1099/0022-1317-82-6-1273 via crossref
- doi:10.1128/jvi.75.24.12359-12369.2001 via crossref
- doi:10.1128/jvi.76.21.11065-11078.2002 via crossref
- doi:10.1128/jvi.79.5.3097-3106.2005 via crossref
- doi:10.1128/jvi.80.7.3670-3674.2006 via crossref
- doi:10.1128/jvi.00385-06 via crossref
- doi:10.1128/jvi.02339-07 via crossref
- doi:10.1128/jvi.01804-08 via crossref
- doi:10.1371/journal.pone.0032857 via crossref
- doi:10.1128/jvi.00189-12 via crossref
- doi:10.1073/pnas.1311542110 via crossref
- doi:10.1128/mbio.00650-13 via crossref
- doi:10.1099/vir.0.000184 via crossref
- doi:10.1080/22221751.2019.1701391 via crossref
- doi:10.1016/j.chom.2020.04.004 via crossref
- doi:10.1128/mbio.02168-20 via crossref
- doi:10.1371/journal.pbio.3001091 via crossref
- doi:10.1128/jvi.02209-20 via crossref
- doi:10.1016/j.virusres.2023.199286 via crossref
- doi:10.3390/ijms221910188 via crossref
- doi:10.1016/j.celrep.2021.109014 via crossref
- doi:10.1038/s41467-021-23779-5 via crossref
- doi:10.1186/s12985-023-02025-y via crossref
- doi:10.1073/pnas.2310421121 via crossref
- doi:10.1038/s41467-023-37787-0 via crossref
- doi:10.15252/embr.202153820 via crossref
- doi:10.7554/elife.89035.3 via crossref
- doi:10.1016/j.virol.2019.08.006 via crossref
- doi:10.1038/s41586-020-2294-9 via crossref
- doi:10.3389/fmicb.2023.1141101 via crossref
- doi:10.1007/s00412-016-0588-3 via crossref
- doi:10.1128/mspheredirect.00331-17 via crossref
- doi:10.1073/pnas.1700534114 via crossref
- doi:10.1016/j.crmeth.2024.100696 via crossref
- doi:10.3389/fmicb.2022.787739 via crossref
- doi:10.1016/j.antiviral.2021.105233 via crossref
- doi:10.1038/srep20889 via crossref
- doi:10.1128/aac.00814-16 via crossref
- doi:10.1073/pnas.94.14.7384 via crossref
- doi:10.1126/science.1151721 via crossref
- doi:10.1126/science.1190719 via crossref
- doi:10.1016/j.cell.2023.09.025 via crossref
- doi:10.1128/jvi.62.8.2674-2679.1988 via crossref
- doi:10.1128/jvi.62.12.4439-4444.1988 via crossref
- doi:10.1073/pnas.1735582100 via crossref
- doi:10.1007/978-0-387-33012-9_88 via crossref
- doi:10.2217/fvl-2018-0008 via crossref
- doi:10.1021/jacsau.1c00139 via crossref
- doi:10.1038/s41467-021-25796-w via crossref
- doi:10.1038/s41586-022-05148-4 via crossref
- doi:10.1016/j.virusres.2014.11.021 via crossref
- doi:10.1128/jvi.02699-12 via crossref
- doi:10.1038/s41467-020-18440-6 via crossref
- doi:10.1128/jvi.01986-15 via crossref
- doi:10.1093/nar/16.22.10849 via crossref
- doi:10.1128/jvi.69.12.7851-7856.1995 via crossref
- doi:10.1126/science.abl478 via crossref
- doi:10.1016/j.antiviral.2022.105343 via crossref
- doi:10.1016/j.antiviral.2023.105555 via crossref
- doi:10.1128/jvi.67.6.3304-3311.1993 via crossref
- doi:10.1038/s41591-020-1083-1 via crossref
- doi:10.7554/elife.64509 via crossref
- doi:10.1016/j.jcv.2021.104847 via crossref
- doi:10.1038/nmeth.2888 via crossref
- doi:10.1126/science.1173759 via crossref
- doi:10.1038/nprot.2008.5 via crossref
- doi:10.1371/journal.pone.0001420 via crossref
- doi:10.1016/j.xpro.2022.101515 via crossref
Source provenance
- crossref
- last seen: 2026-05-20T01:00:12.947224+00:00
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00